The Human Microbiome in Intensive Care - A Journey Forward?
References
- Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59–65.
- Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174–80.
- Liu W, Cheng M, Li J, Zhang P, Fan H, Hu Q, et al. Classification of the gut microbiota of patients in intensive care units during development of sepsis and septic shock. Genomics, Proteomics Bioinformatics. 2020;18(6):696–707.
- Amon P, Sanderson I. What is the microbiome? Arch Dis Child Educ Pract Ed. 2017;102(5):257–60.
- Szychowiak P, Villageois-Tran K, Patrier J, Timsit JF, Ruppe E. The role of the microbiota in the management of intensive care patients. Ann Intensive Care. 2022;12(1):3.
- Wolf AJ, Underhill DM. Peptidoglycan recognition by the innate immune system. Nat Rev Immunol. 2018;18:243–54.
- Emonet S, Lazarevic V, Leemann Refondini C, Gaia N, Leo S, Girard M, et al. Identification of respiratory microbiota markers in ventilator-associated pneumonia. Intensive Care Med. 2019;45:1082–92.
- Wolff NS, Hugenholtz F, Wiersinga WJ. The emerging role of the microbiota in the ICU. Crit Care. 2018;22(1):78.
- Schlechte J, Zucoloto AZ., Yu IL, Doig CJ, Dunbar MJ, McCoy KD, et al. Dysbiosis of a microbiota–immune metasystem in critical illness is associated with nosocomial infections. Nat Med. 2023;29(4):1017–27.
- Lankelma JM, van Vught LA, Belzer C, Schultz MJ, van der Poll T, de Vos WM, et al. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study. Intensive Care Med. 2017;43:59–68.
- Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med. 2010;38:954–62.
- Azamfirei L. Personalized physiological medicine as the future of intensive care medicine. J Crit Care Med. 2022;8(3):143–4.
- Lazăr A, Azamfirei L. Personalized medicine for the critically ill patient: a narrative review. Processes. 2022;10(6).
- Behrouzi A, Nafari AH, Siadat SD. The significance of microbiome in personalized medicine. Clin Transl Med. 2019;8(1):16.
- Georgescu AM, Bănescu C, Badea I, Moldovan V, Hutanu A, Voidazan S, et al. IL-6 gene polymorphisms and sepsis in ICU adult Romanian patients: a prospective study. Rev Romana Med Lab. 2017;25(1):75–89.
- Lazăr A, Georgescu AM, Vitin A, Azamfirei L. Precision Medicine and its role in the treatment of sepsis: a personalised view. J Crit Care Med. 2019;5:90–6.
- Kashyap PC, Chia N, Nelson H, Segal E, Elinav E. Microbiome at the frontier of personalized medicine. Mayo Clin Proc. 2017;92(12):1855–64.
- Di Domenico M, Ballini A, Boccellino M, Scacco S, Lovero R, Charitos IA, et al. The intestinal microbiota may be a potential theranostic tool for personalized medicine. J Pers Med. 2022;12:523.
Language: English
Page range: 205 - 207
Submitted on: Oct 24, 2023
Accepted on: Oct 26, 2023
Published on: Nov 14, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2023 Leonard Azamfirei, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.